BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1734494)

  • 1. Production of heterohybridomas secreting autoreactive and polyreactive human monoclonal antibodies.
    Sanchez B; Yelamos J; Melero J; Magariño R; Gonzalez MF; Garcia R; Rios C; Nuñez-Roldan A
    Scand J Immunol; 1992 Jan; 35(1):33-41. PubMed ID: 1734494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity.
    Lydyard PM; Quartey-Papafio R; Bröker B; Mackenzie L; Jouquan J; Blaschek MA; Steele J; Petrou M; Collins P; Isenberg D
    Scand J Immunol; 1990 Jan; 31(1):33-43. PubMed ID: 2154032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymphocytotoxic monoclonal autoantibodies from a highly sensitized renal dialysis patient.
    Robledo MM; Melero J; Dinca L; Tarragó D; García-Lozano JR; Núñez-Roldán A; Sánchez B
    Transplantation; 1995 Jun; 59(11):1613-7. PubMed ID: 7778177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyreactivity of human monoclonal antibodies: human anti-Rh monoclonal antibodies of IgM isotype are frequently polyreactive.
    Blancher A; Roubinet F; Oksman F; Ternynck T; Broly H; Chevaleyre J; Vezon G; Ducos J
    Vox Sang; 1991; 61(3):196-204. PubMed ID: 1807061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of human monoclonal lymphocytotoxic autoantibodies from a renal dialysis patient.
    Taylor CJ; Ting A; Morris PJ
    Tissue Antigens; 1991 Mar; 37(3):112-20. PubMed ID: 1871763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and analysis of IgG monoclonal anti-DNA antibodies from systemic lupus erythematosus (SLE) patients.
    Ehrenstein M; Longhurst C; Isenberg DA
    Clin Exp Immunol; 1993 Apr; 92(1):39-45. PubMed ID: 8385586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG.
    Melero J; Tarragó D; Núñez-Roldán A; Sánchez B
    Scand J Immunol; 1997 Apr; 45(4):393-400. PubMed ID: 9105427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
    Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
    Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human monoclonal antibodies to myeloperoxidase.
    Ehrenstein MR; Leaker B; Isenberg D; Cambridge G
    Immunology; 1992 Dec; 77(4):617-20. PubMed ID: 1337335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-bacterial specificities in the human fetal B cell repertoire.
    Settmacher U; Delvig A; Jahn S
    Hum Antibodies Hybridomas; 1994; 5(1-2):91-5. PubMed ID: 7858188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-binding diversity of human hybridoma autoantibodies derived from splenocytes of patients with SLE.
    Ravirajan CT; Kalsi J; Wiloch HW; Barakat S; Tuaillon N; Irvine W; Cockayne A; Harris A; Williams DG; Williams W
    Lupus; 1992 May; 1(3):157-65. PubMed ID: 1301976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of cellular ELISA (CELISA) to the detection of human monoclonal autoantibodies.
    Sánchez B; Melero J; Robledo MM; Tarragó D; Yélamos J; González MF
    Hum Antibodies Hybridomas; 1993 Oct; 4(4):198-202. PubMed ID: 8257774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive.
    Nakamura M; Burastero SE; Notkins AL; Casal P
    J Immunol; 1988 Jun; 140(12):4180-6. PubMed ID: 3259609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding specificities of a polyreactive and a monoreactive human monoclonal IgG rheumatoid factor: role of oligosaccharides.
    al-Balaghi S; Abedi-Valugerdi M; Möller E
    Scand J Immunol; 1996 Nov; 44(5):470-7. PubMed ID: 8947598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal anti-nuclear antibodies produced by human-mouse heterohybridomas.
    Someya A; Kondo H
    Clin Exp Immunol; 1986 Jan; 63(1):26-31. PubMed ID: 3514012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G; Cruz C
    Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.